BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2327439)

  • 1. Third-generation cephalosporins: a decade of progress in the treatment of severe infections. June 13, 1989. Proceedings.
    Am J Med; 1990 Apr; 88(4A):1S-45S. PubMed ID: 2327439
    [No Abstract]   [Full Text] [Related]  

  • 2. Third generation cephalosporins in the treatment of severe infections. Workshop held during the 16th ICC. Jerusalem, June 11-16, 1989. Proceedings.
    Chemotherapy; 1989; 35 Suppl 2():1-42. PubMed ID: 2612234
    [No Abstract]   [Full Text] [Related]  

  • 3. [The third generation of cephalosporins or aminoglycosides?].
    Solberg CO
    Tidsskr Nor Laegeforen; 1986 Feb; 106(5):418-9. PubMed ID: 3961764
    [No Abstract]   [Full Text] [Related]  

  • 4. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Third-generation cephalosporins in the treatment of exacerbations in chronic obstructive lung diseases].
    Carrion Valero F
    An Med Interna; 1995 Dec; 12(12):623. PubMed ID: 8679815
    [No Abstract]   [Full Text] [Related]  

  • 6. The third generation cephalosporins.
    Farber B; Moellering RC
    Bull N Y Acad Med; 1982 Nov; 58(8):696-710. PubMed ID: 6762896
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibiotic therapy in the cancer patient: focus on third generation cephalosporins.
    Link DL
    Oncol Nurs Forum; 1987; 14(5):35-41. PubMed ID: 3658775
    [No Abstract]   [Full Text] [Related]  

  • 8. Third generation cephalosporins.
    Singhal PK; Patwari AK; Kanodia KK; Mullick DN
    Indian Pediatr; 1987 Dec; 24(12):1131-5. PubMed ID: 3330059
    [No Abstract]   [Full Text] [Related]  

  • 9. Cephalosporins: bridging the generation gap.
    Kane JG
    Am Fam Physician; 1982 May; 25(5):177-83. PubMed ID: 7072575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cephalosporins. Therapeutic progress].
    Gutiérrez-Núñez JJ; Harrington PT; Quiñones Soto R; Bermûdez RH; Ramírez Ronda CH
    Bol Asoc Med P R; 1980 Oct; 72(10):518-26. PubMed ID: 6934776
    [No Abstract]   [Full Text] [Related]  

  • 11. Cephalosporin antibiotics as applied in surgery of bones and joints.
    Neu HC
    Clin Orthop Relat Res; 1984 Nov; (190):50-64. PubMed ID: 6386261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newer antibiotics: their place in geriatric care. Part I.
    Gleckman RA; Bergman MM
    Geriatrics; 1986 Dec; 41(12):51-5. PubMed ID: 3465671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Criteria for selection of the first, second and third generation cephem antibiotics. 1. Internal medicine].
    Watanabe A; Konno K
    Nihon Rinsho; 1984 Mar; 42(3):706-7. PubMed ID: 6471463
    [No Abstract]   [Full Text] [Related]  

  • 14. [Criteria for selection of the first, second and third generation cephem antibiotics. 1. Internal medicine].
    Katsu M
    Nihon Rinsho; 1984 Mar; 42(3):701-2. PubMed ID: 6471461
    [No Abstract]   [Full Text] [Related]  

  • 15. [Criteria for selection of the first, second and third generation cephem antibiotics. 2. Surgery].
    Yura J
    Nihon Rinsho; 1984 Mar; 42(3):711-2. PubMed ID: 6471465
    [No Abstract]   [Full Text] [Related]  

  • 16. [Third generation cephalosporins, monobactams and carbapenems].
    Perronne C; Vildé JL
    Rev Prat; 1988 Mar; 38(8):469-76. PubMed ID: 3163818
    [No Abstract]   [Full Text] [Related]  

  • 17. Is there still a role for penicillins and cephalosporins in the treatment of bacterial infections?
    Moreillon P; Majcherczyk P
    Int J Clin Pract Suppl; 2000 Dec; (115):99-105. PubMed ID: 11219310
    [No Abstract]   [Full Text] [Related]  

  • 18. Ceftriaxone: increasing the half-life and activity of third generation cephalosporins.
    Steele RW
    Pediatr Infect Dis; 1985; 4(2):188-91. PubMed ID: 3885182
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro activity, pharmacokinetics, clinical efficacy, safety and pharmacoeconomics of ceftriaxone compared with third and fourth generation cephalosporins: review.
    Bijie H; Kulpradist S; Manalaysay M; Soebandrio A
    J Chemother; 2005 Feb; 17(1):3-24. PubMed ID: 15828439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of third-generation cephalosporins in infections in organ transplantation recipients].
    Gobernado Serrano M
    Rev Clin Esp; 1995 Oct; 195 Spec No():59-63. PubMed ID: 8948738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.